Latest filing published 05 Feb 2024 for Arbutus Biopharma Corporation.
No signal scores available.
Michael Joseph Sofia appears in our data through filings on Arbutus Biopharma Corporation shares, published by SEDI. The record holds 7 filings, for trades running from 4 March 2015 to 2 February 2024.
Every open-market trade on record is a sale: 3 sales worth €16k. The totals exclude 2 filings filed without an amount. Other entries cover 2 share grants. In 2024 alone, the filings show no purchases and 1 sale.
On 5 February 2024 came the latest disclosure, an open-market sale for €16k in Arbutus Biopharma Corporation. Filings reach the SEDI feed a median of 4 days after the trade. That lag is the time during which only the insider knows about the trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations